Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 19 | 2021 | 688 | 1.240 |
Why?
|
| Prosthesis-Related Infections | 13 | 2021 | 222 | 1.240 |
Why?
|
| Arthroplasty, Replacement, Hip | 22 | 2021 | 860 | 1.220 |
Why?
|
| Pain, Postoperative | 12 | 2019 | 334 | 0.930 |
Why?
|
| Hip Prosthesis | 10 | 2019 | 578 | 0.750 |
Why?
|
| Surgical Wound Infection | 4 | 2022 | 103 | 0.540 |
Why?
|
| Prosthesis Failure | 10 | 2019 | 539 | 0.520 |
Why?
|
| Synovial Fluid | 7 | 2016 | 127 | 0.510 |
Why?
|
| Anesthetics, Local | 4 | 2016 | 97 | 0.460 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 782 | 0.460 |
Why?
|
| Middle Aged | 40 | 2020 | 10192 | 0.450 |
Why?
|
| Analgesics | 4 | 2018 | 109 | 0.450 |
Why?
|
| Anti-Bacterial Agents | 5 | 2021 | 420 | 0.430 |
Why?
|
| Male | 47 | 2020 | 16425 | 0.430 |
Why?
|
| Female | 45 | 2020 | 16965 | 0.410 |
Why?
|
| Pain Measurement | 11 | 2017 | 489 | 0.410 |
Why?
|
| Dexamethasone | 3 | 2016 | 48 | 0.400 |
Why?
|
| Bupivacaine | 3 | 2016 | 57 | 0.400 |
Why?
|
| Aged | 36 | 2020 | 10047 | 0.390 |
Why?
|
| Reoperation | 18 | 2021 | 950 | 0.380 |
Why?
|
| Hip Joint | 7 | 2014 | 406 | 0.350 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 128 | 0.350 |
Why?
|
| Treatment Outcome | 22 | 2021 | 3806 | 0.350 |
Why?
|
| Knee Joint | 6 | 2020 | 826 | 0.350 |
Why?
|
| Nerve Block | 3 | 2017 | 65 | 0.350 |
Why?
|
| Periprosthetic Fractures | 3 | 2016 | 32 | 0.330 |
Why?
|
| Hip Dislocation | 4 | 2015 | 68 | 0.330 |
Why?
|
| Pain Management | 4 | 2018 | 144 | 0.330 |
Why?
|
| Adult | 27 | 2017 | 8924 | 0.320 |
Why?
|
| Humans | 49 | 2021 | 30959 | 0.320 |
Why?
|
| Complex Regional Pain Syndromes | 2 | 2020 | 25 | 0.310 |
Why?
|
| Analgesia, Epidural | 3 | 2018 | 59 | 0.310 |
Why?
|
| Ketamine | 2 | 2019 | 35 | 0.300 |
Why?
|
| Knee Prosthesis | 4 | 2020 | 240 | 0.290 |
Why?
|
| Pain, Intractable | 1 | 2007 | 15 | 0.290 |
Why?
|
| Terrorism | 1 | 2007 | 13 | 0.290 |
Why?
|
| Ketorolac | 2 | 2016 | 18 | 0.270 |
Why?
|
| Postoperative Hemorrhage | 2 | 2017 | 26 | 0.270 |
Why?
|
| Motor Activity | 4 | 2017 | 370 | 0.270 |
Why?
|
| Antifibrinolytic Agents | 2 | 2017 | 21 | 0.270 |
Why?
|
| Tranexamic Acid | 2 | 2017 | 21 | 0.270 |
Why?
|
| Analgesics, Opioid | 4 | 2017 | 226 | 0.260 |
Why?
|
| Depressive Disorder | 1 | 2007 | 191 | 0.260 |
Why?
|
| Femur | 4 | 2019 | 402 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 103 | 0.250 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 82 | 0.250 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 20 | 0.250 |
Why?
|
| Arousal | 1 | 2005 | 44 | 0.250 |
Why?
|
| Aged, 80 and over | 18 | 2016 | 5189 | 0.250 |
Why?
|
| Fear | 1 | 2005 | 47 | 0.250 |
Why?
|
| Models, Psychological | 1 | 2005 | 71 | 0.250 |
Why?
|
| Analgesia | 3 | 2016 | 43 | 0.240 |
Why?
|
| Retrospective Studies | 16 | 2021 | 3658 | 0.240 |
Why?
|
| Attitude to Health | 1 | 2005 | 100 | 0.230 |
Why?
|
| Sciatic Nerve | 2 | 2016 | 32 | 0.220 |
Why?
|
| Low Back Pain | 1 | 2005 | 144 | 0.220 |
Why?
|
| Arthritis, Infectious | 2 | 2016 | 63 | 0.220 |
Why?
|
| Animals | 11 | 2022 | 4722 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2015 | 32 | 0.210 |
Why?
|
| Bone Resorption | 2 | 2014 | 97 | 0.210 |
Why?
|
| Time Factors | 10 | 2016 | 1672 | 0.200 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2016 | 40 | 0.190 |
Why?
|
| Immunologic Factors | 1 | 2022 | 42 | 0.190 |
Why?
|
| Pseudomonas Infections | 1 | 2022 | 60 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2022 | 79 | 0.190 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 2 | 2014 | 245 | 0.180 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 48 | 0.180 |
Why?
|
| Joint Instability | 3 | 2014 | 405 | 0.180 |
Why?
|
| Prospective Studies | 10 | 2016 | 1897 | 0.180 |
Why?
|
| Mice | 6 | 2022 | 1683 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2018 | 468 | 0.180 |
Why?
|
| Risk Factors | 10 | 2019 | 2586 | 0.180 |
Why?
|
| Shoulder Joint | 2 | 2017 | 605 | 0.180 |
Why?
|
| Blood Sedimentation | 6 | 2016 | 65 | 0.170 |
Why?
|
| Edema | 1 | 2020 | 40 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 24 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 37 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2019 | 15 | 0.170 |
Why?
|
| Hypoglycemic Agents | 2 | 2020 | 60 | 0.160 |
Why?
|
| Neuralgia | 1 | 2019 | 15 | 0.160 |
Why?
|
| Clonidine | 2 | 2016 | 28 | 0.160 |
Why?
|
| Acetabulum | 2 | 2012 | 203 | 0.160 |
Why?
|
| Shoulder Dislocation | 2 | 2017 | 102 | 0.160 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 42 | 0.160 |
Why?
|
| Vancomycin | 1 | 2018 | 59 | 0.150 |
Why?
|
| Acute Pain | 1 | 2018 | 20 | 0.150 |
Why?
|
| Prosthesis Design | 2 | 2019 | 507 | 0.150 |
Why?
|
| Leukocyte Count | 5 | 2016 | 93 | 0.150 |
Why?
|
| Random Allocation | 4 | 2020 | 147 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 466 | 0.140 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 310 | 0.140 |
Why?
|
| Administration, Oral | 4 | 2018 | 139 | 0.140 |
Why?
|
| Laparotomy | 1 | 2016 | 29 | 0.140 |
Why?
|
| Buprenorphine | 1 | 2016 | 6 | 0.140 |
Why?
|
| Pain Threshold | 1 | 2016 | 22 | 0.140 |
Why?
|
| Foreign-Body Reaction | 1 | 2016 | 28 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2016 | 71 | 0.130 |
Why?
|
| Range of Motion, Articular | 4 | 2020 | 736 | 0.130 |
Why?
|
| Joints | 1 | 2016 | 99 | 0.130 |
Why?
|
| Morphine | 1 | 2016 | 85 | 0.130 |
Why?
|
| Hemoglobins | 1 | 2016 | 82 | 0.130 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2014 | 281 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 31 | 0.120 |
Why?
|
| Femur Head | 1 | 2015 | 67 | 0.120 |
Why?
|
| Osteoarthritis, Knee | 3 | 2014 | 400 | 0.120 |
Why?
|
| Nutritional Status | 1 | 2015 | 46 | 0.120 |
Why?
|
| Malnutrition | 1 | 2015 | 21 | 0.120 |
Why?
|
| Arthralgia | 1 | 2016 | 133 | 0.120 |
Why?
|
| Insulin | 1 | 2015 | 97 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2015 | 120 | 0.120 |
Why?
|
| General Surgery | 1 | 2015 | 58 | 0.120 |
Why?
|
| Metal-on-Metal Joint Prostheses | 1 | 2015 | 54 | 0.120 |
Why?
|
| Anesthesia, Epidural | 2 | 2011 | 25 | 0.120 |
Why?
|
| Joint Prosthesis | 1 | 2015 | 79 | 0.110 |
Why?
|
| Rotator Cuff Injuries | 1 | 2017 | 298 | 0.110 |
Why?
|
| Double-Blind Method | 5 | 2017 | 499 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 118 | 0.110 |
Why?
|
| Microbiological Techniques | 1 | 2013 | 9 | 0.110 |
Why?
|
| ROC Curve | 4 | 2016 | 145 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1133 | 0.110 |
Why?
|
| Drainage | 1 | 2013 | 52 | 0.110 |
Why?
|
| Sepsis | 1 | 2015 | 154 | 0.110 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 150 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 185 | 0.110 |
Why?
|
| Arthroplasty | 1 | 2014 | 141 | 0.100 |
Why?
|
| Pelvic Bones | 1 | 2012 | 20 | 0.100 |
Why?
|
| Osteotomy | 1 | 2014 | 171 | 0.100 |
Why?
|
| Incidence | 4 | 2017 | 785 | 0.100 |
Why?
|
| Sutures | 1 | 2012 | 46 | 0.100 |
Why?
|
| Triage | 1 | 2012 | 23 | 0.100 |
Why?
|
| Braces | 1 | 2012 | 26 | 0.100 |
Why?
|
| Femoral Fractures | 1 | 2012 | 42 | 0.100 |
Why?
|
| Sex Factors | 3 | 2012 | 510 | 0.100 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2011 | 15 | 0.100 |
Why?
|
| Substance P | 1 | 2011 | 18 | 0.100 |
Why?
|
| Norepinephrine | 1 | 2011 | 21 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2011 | 33 | 0.100 |
Why?
|
| Causality | 2 | 2011 | 54 | 0.100 |
Why?
|
| Povidone-Iodine | 1 | 2011 | 7 | 0.100 |
Why?
|
| Joint Diseases | 1 | 2012 | 114 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 104 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 549 | 0.090 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 24 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 1922 | 0.090 |
Why?
|
| Catheterization | 1 | 2011 | 51 | 0.090 |
Why?
|
| Knee Injuries | 1 | 2014 | 238 | 0.090 |
Why?
|
| Warfarin | 1 | 2011 | 38 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2011 | 53 | 0.090 |
Why?
|
| Awards and Prizes | 3 | 2017 | 24 | 0.090 |
Why?
|
| Patient Selection | 1 | 2012 | 246 | 0.090 |
Why?
|
| Injections | 3 | 2016 | 59 | 0.090 |
Why?
|
| Diabetic Neuropathies | 1 | 2010 | 14 | 0.090 |
Why?
|
| Amides | 1 | 2010 | 21 | 0.090 |
Why?
|
| Biomarkers | 4 | 2015 | 733 | 0.090 |
Why?
|
| Lidocaine | 1 | 2010 | 44 | 0.090 |
Why?
|
| Drug Administration Schedule | 3 | 2016 | 225 | 0.090 |
Why?
|
| Postoperative Complications | 5 | 2017 | 991 | 0.090 |
Why?
|
| Logistic Models | 3 | 2016 | 409 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2009 | 532 | 0.080 |
Why?
|
| Chicago | 4 | 2015 | 943 | 0.080 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2008 | 15 | 0.080 |
Why?
|
| Dexmedetomidine | 1 | 2008 | 4 | 0.080 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2008 | 17 | 0.080 |
Why?
|
| Craniotomy | 1 | 2008 | 29 | 0.080 |
Why?
|
| Pain | 2 | 2018 | 426 | 0.080 |
Why?
|
| Heart Rate | 1 | 2008 | 156 | 0.070 |
Why?
|
| United States | 4 | 2017 | 2373 | 0.070 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2007 | 11 | 0.070 |
Why?
|
| Young Adult | 4 | 2015 | 2060 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2008 | 261 | 0.070 |
Why?
|
| Recovery of Function | 3 | 2017 | 298 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 583 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2016 | 68 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2013 | 2042 | 0.070 |
Why?
|
| Administration, Intravenous | 2 | 2017 | 28 | 0.070 |
Why?
|
| Radiography | 3 | 2014 | 695 | 0.070 |
Why?
|
| Health Care Surveys | 2 | 2017 | 68 | 0.070 |
Why?
|
| Prevalence | 3 | 2012 | 500 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2006 | 26 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 291 | 0.070 |
Why?
|
| Disability Evaluation | 2 | 2005 | 333 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 171 | 0.070 |
Why?
|
| Interleukins | 1 | 2006 | 38 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2006 | 56 | 0.060 |
Why?
|
| Behavior, Animal | 2 | 2016 | 105 | 0.060 |
Why?
|
| Walking | 2 | 2018 | 259 | 0.060 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2017 | 77 | 0.060 |
Why?
|
| Personality Assessment | 1 | 2005 | 41 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 79 | 0.060 |
Why?
|
| Perioperative Period | 2 | 2017 | 12 | 0.060 |
Why?
|
| Metals | 2 | 2016 | 154 | 0.060 |
Why?
|
| Age Distribution | 2 | 2015 | 96 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2015 | 89 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 199 | 0.060 |
Why?
|
| Wound Closure Techniques | 2 | 2016 | 10 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2005 | 299 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 111 | 0.060 |
Why?
|
| Area Under Curve | 2 | 2014 | 70 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2005 | 147 | 0.060 |
Why?
|
| Lactones | 1 | 2003 | 14 | 0.060 |
Why?
|
| Arthroscopy | 3 | 2017 | 892 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2003 | 52 | 0.060 |
Why?
|
| Recurrence | 2 | 2017 | 369 | 0.050 |
Why?
|
| Operative Time | 2 | 2014 | 85 | 0.050 |
Why?
|
| Rats | 2 | 2018 | 873 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 1316 | 0.050 |
Why?
|
| Early Diagnosis | 2 | 2014 | 69 | 0.050 |
Why?
|
| Acute Disease | 2 | 2015 | 231 | 0.050 |
Why?
|
| Drug Evaluation | 1 | 2022 | 54 | 0.050 |
Why?
|
| Blood Loss, Surgical | 2 | 2017 | 67 | 0.050 |
Why?
|
| Anterior Cruciate Ligament Injuries | 2 | 2014 | 274 | 0.050 |
Why?
|
| Pregabalin | 2 | 2011 | 22 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2022 | 323 | 0.050 |
Why?
|
| Activities of Daily Living | 2 | 2015 | 551 | 0.040 |
Why?
|
| Tibial Fractures | 1 | 2020 | 13 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 1210 | 0.040 |
Why?
|
| Prognosis | 2 | 2012 | 919 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 1009 | 0.040 |
Why?
|
| Rodentia | 1 | 2018 | 8 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2018 | 53 | 0.040 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 2011 | 29 | 0.040 |
Why?
|
| Femoral Nerve | 1 | 2018 | 10 | 0.040 |
Why?
|
| Thigh | 1 | 2017 | 32 | 0.040 |
Why?
|
| Anesthesia, Conduction | 1 | 2017 | 30 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 2399 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 68 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2017 | 52 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 429 | 0.030 |
Why?
|
| Vasculitis | 1 | 2016 | 31 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2017 | 67 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 18 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 130 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 302 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 56 | 0.030 |
Why?
|
| Cost Savings | 1 | 2016 | 33 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 353 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 246 | 0.030 |
Why?
|
| Streptozocin | 1 | 2015 | 6 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2015 | 15 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 120 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2006 | 32 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2015 | 34 | 0.030 |
Why?
|
| Rotator Cuff | 1 | 2017 | 283 | 0.030 |
Why?
|
| Corrosion | 1 | 2015 | 133 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 23 | 0.030 |
Why?
|
| Polyethylene | 1 | 2015 | 121 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 219 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2014 | 41 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 99 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 341 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 42 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2013 | 21 | 0.030 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2014 | 98 | 0.030 |
Why?
|
| Medicaid | 1 | 2013 | 39 | 0.030 |
Why?
|
| Tantalum | 1 | 2012 | 35 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2013 | 75 | 0.030 |
Why?
|
| Osteoarthritis, Hip | 1 | 2013 | 95 | 0.030 |
Why?
|
| Medicare | 1 | 2013 | 127 | 0.030 |
Why?
|
| Menisci, Tibial | 1 | 2014 | 187 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 14 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 148 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 336 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 370 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 104 | 0.030 |
Why?
|
| Disease Management | 1 | 2013 | 126 | 0.020 |
Why?
|
| Spinal Puncture | 1 | 2011 | 30 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 817 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2011 | 27 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 413 | 0.020 |
Why?
|
| Philadelphia | 1 | 2011 | 5 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2011 | 71 | 0.020 |
Why?
|
| Suction | 1 | 2011 | 48 | 0.020 |
Why?
|
| Tibia | 1 | 2013 | 274 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2010 | 6 | 0.020 |
Why?
|
| Sensation | 1 | 2010 | 17 | 0.020 |
Why?
|
| Epinephrine | 1 | 2010 | 37 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 54 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 344 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2009 | 34 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 872 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 716 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2008 | 5 | 0.020 |
Why?
|
| Methyl Ethers | 1 | 2008 | 6 | 0.020 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 11 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 339 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2008 | 136 | 0.020 |
Why?
|
| Sleep | 1 | 2009 | 322 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2006 | 32 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2006 | 79 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2006 | 112 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2006 | 176 | 0.020 |
Why?
|
| Dyssomnias | 1 | 2003 | 8 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 351 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 28 | 0.010 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 18 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 35 | 0.010 |
Why?
|
| Sulfones | 1 | 2003 | 25 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2003 | 56 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 184 | 0.010 |
Why?
|
| Depression | 1 | 2005 | 481 | 0.010 |
Why?
|